Project | Class | Disease | Patient number | Sample numbera | Average number of mutationsb | Average number of neoepitope (≤500 nM)b | Average number of expressed neoepitopesb |
---|---|---|---|---|---|---|---|
PCGP | LEUKEMIA | ETV | 49 | 56 (7) | 11.22 (20.73) | 4.29 (9.25) | 1.68 (4.09) |
HYPER | 53 | 53 | 9.49 | 4.11 | - | ||
BALL | 31 | 31 | 11.58 | 5.03 | 2.00 | ||
HYPO | 22 | 22 | 9.64 | 3.23 | 1.50 | ||
TALL | 10 | 10 | 8.10 | 3.60 | - | ||
ERG | 25 | 25 | 8.40 | 3.16 | 1.28 | ||
CBF | 16 | 16 | 6.38 | 2.13 | 0.89 | ||
INF | 19 | 21(2) | 2.47 (3.57) | 1.11 (1.52) | 0.44 (0.44) | ||
PHALL | 35 | 35 | 4.49 | 1.83 | 0.52 | ||
E2A | 21 | 21 | 5.48 | 2.10 | - | ||
AMLM7 | 3 | 3 | 2.67 | 0.67 | 0.33 | ||
Subtotal | 284 | 293 | Â | Â | Â | ||
CNS | HGG | 32 | 35 (3) | 17.97 (17.46) | 8.59 (8.20) | 3.68 (3.56) | |
EPD | 32 | 34 (2) | 5.06 (5.68) | 1.78 (1.91) | 0.93 (0.96) | ||
MB | 34 | 34 | 8.94 | 3.68 | 4.25 | ||
LGG | 23 | 23 | 1.74 | 0.65 | 0.33 | ||
CPC | 2 | 2 | 2.00 | 1.50 | - | ||
Subtotal | 123 | 128 | Â | Â | Â | ||
SOLID | MEL | 4 | 4 | 112.25 | 51.25 | 6.00 | |
NBL | 44 | 47 (3) | 15.2 (16.62) | 7.09 (7.79) | - | ||
ACT | 20 | 20 | 11.75 | 3.70 | 1.75 | ||
RHB | 14 | 15 (1) | 15.14 (18.00) | 6.71 (8.13) | 2.08 (3.14) | ||
OS | 27 | 27 | 18.22 | 7.07 | 2.92 | ||
RB | 5 | 5 | 5.20 | 2.40 | - | ||
EWS | 19 | 19 | 5.63 | 2.00 | - | ||
Subtotal | 133 | 137 | Â | Â | Â | ||
TCGA | Â | LUAD | 129 | 129 | 226.63 | 95.74 | 36.99 |
LUSC | 33 | 33 | 224.58 | 95.88 | 58.06 | ||
SKCM | 133 | 133 | 411.50 | 167.57 | 60.64 | ||
Subtotal | 295 | 295 | Â | Â | Â |